Kamdar and colleagues performed survival analysis of a PCa patient cohort taken from The Cancer Genome Atlas (TCGA) and showed that reduction in ASB2, NUDT10, and SRPX expression was significantly associated with lower recurrence‐free survival. The gene discussed is ASB2; the disease is posterior cortical atrophy.